- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VERV
Recent news which mentions VERV
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 31, 2023
From Benzinga
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
October 31, 2023
From Benzinga
Why Beam Therapeutics Stock Is Getting Bought Today
October 31, 2023
From Benzinga
With 1 Roadblock Down, Is Verve Therapeutics a Buy Now?
October 30, 2023
Tickers
VERV
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 27, 2023
From Benzinga
2 Incredible Growth Stocks Near 52-Week Lows to Buy Now
October 10, 2023
From Motley Fool
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
From Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 29, 2023
From Benzinga
From Benzinga
From Benzinga
Tickers
VERV
From Motley Fool
From Benzinga
Cathie Wood Continues To Sell Tesla Shares Amid Q2 Deliveries-Induced Strength: Here's How Much Shares Ark Offloaded Monday
July 03, 2023
From Benzinga
From Benzinga
Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results
June 15, 2023
From Benzinga
Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday
June 15, 2023
From Benzinga
From Motley Fool
From Benzinga
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday
April 13, 2023
From Benzinga
From Benzinga
Better Buy: Beam Therapeutics or Intellia Therapeutics?
February 22, 2023
From Motley Fool
3 Deeply Undervalued Stocks That Could Double Your Money
February 15, 2023
From Motley Fool
Being Cautious On Regulatory/Commercial Path, This Analyst Initiates Coverage On Verve Therapeutics
February 01, 2023
Tickers
VERV
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
From Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
January 30, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.